Status:
COMPLETED
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The aim of this study is to look at the effects of Aerobic Exercise (AE) on daily and neurocognitive functioning including memory, attention, the ability to plan activities, and learn new information....
Detailed Description
Individuals with schizophrenia often display cognitive difficulties. Studies among non-clinical populations suggest that Aerobic Exercise (AE) training is effective in increasing both aerobic fitness ...
Eligibility Criteria
Inclusion
- Males and females between ages 18-55.
- Have capacity to give informed consent.
- English speaking.
- Have a DSM-IV diagnosis of schizophrenia.
- Taking antipsychotic medication for at least 8 weeks and on current doses for 4 weeks, and/or injectable depot antipsychotics with no change in last 3 months.
- Medically cleared to exercise.
Exclusion
- Lacks capacity to give informed consent.
- Have used street drugs within the past 4 weeks.
- Have history of of hypertension of cardiac conditions.
- Have history of active suicidal ideation or serious self-destructive behavior.
- Have history of violence or aggressive behavior.
- Have history of neurological or medical conditions known to seriously affect the brain.
- Pregnant or nursing.
- Completing more than 2 hours of moderate or higher levels of aerobic exercise per week.
- Participation in a study of cognition during the previous 2 months.
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01897064
Start Date
April 1 2012
End Date
July 1 2014
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University & New York State Psyciatric Institute
New York, New York, United States, 10032